Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
2(18%)
Results Posted
0%(0 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_1
1
9%
Ph phase_3
1
9%
Ph not_applicable
9
82%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 3Large-scale testing
1(9.1%)
N/ANon-phased studies
9(81.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(7)
Terminated(1)
Other(1)

Detailed Status

Completed7
Recruiting2
Suspended1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
87.5%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (9.1%)
Phase 31 (9.1%)
N/A9 (81.8%)

Trials by Status

suspended19%
terminated19%
completed764%
recruiting218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11